Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Elysium Health received early financing of $6.2M on 2016-01-01.
| Series | Round size | Date |
|---|---|---|
| Series A | $6.2M | 01/2016 |
| Series B | $20M | 12/2016 |
| Debt Financing | $5M | 06/2017 |
| Series C | $40M | 12/2019 |
| Investors | Security type |
|---|---|
| Robert Nelsen | Series B |
| Breyer Capital | Series B |
| Morningside Group | Series B |
| General Catalyst | Series B |
| Sound Ventures LLC | Series B |
| Jim Manzi | Series B |
| Matt Mullenweg | Series B |
| SVB Financial Group | Debt Financing |
| Western Technology Investment | Series C |
| Breyer Capital | Series C |
| GISEV Family Office | Series C |
| General Catalyst | Series C |
| Mayo Clinic Ventures | Series C |
Elysium Health's top competitor, Gilead Sciences, earned an annual revenue of $28.8B.
Elysium Health's smallest competitor is Advaxis with revenue of $250.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 540 |
| Exelixis | $108,978 | $2.2B | 484 | 162 |
| Regulus Therapeutics | $51,006 | $10.0M | 25 | - |
| Amylin Pharmaceuticals | $101,565 | $650.7M | 1,300 | - |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 140 |
| Human Genome Sciences | $70,157 | $131.0M | 1,000 | - |
| Advaxis | $51,754 | $250,000 | 35 | - |
| American Academy of Dermatology | $59,406 | $38.3M | 341 | 2 |
Zippia gives an in-depth look into the details of Elysium Health, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Elysium Health. The employee data is based on information from people who have self-reported their past or current employments at Elysium Health. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Elysium Health. The data presented on this page does not represent the view of Elysium Health and its employees or that of Zippia.
Elysium Health may also be known as or be related to Elysium Health, Elysium Health Inc and Elysium Health, Inc.